ArcticZymes Technologies ASA (LON:0DRV)

Market Cap	65.94M
Revenue (ttm)	7.60M
Net Income (ttm)	532.38K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	123.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	352
Average Volume	1,429
Open	14.50
Previous Close	16.68
Day's Range	14.50 - 14.50
52-Week Range	0.92 - 2.90
Beta	1.36
RSI	38.38
Earnings Date	May 8, 2025

About LON:0DRV

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during man...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 61
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2024, LON:0DRV's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 7.57 million, a decrease of -61.02%.

Financial numbers in NOK